Can Polymorphisms in NLRP3 Inflammasome Complex Be Associated with Postmenopausal Osteoporosis Severity?

Area of Science:

• Immunology
• Genetics
• Bone Biology

Background:

• Estrogen deficiency in postmenopausal women triggers the inflammasome, increasing pro-inflammatory cytokines (IL-1β, IL-18) and impacting bone homeostasis.
• The NLRP3 inflammasome complex is implicated in bone metabolism, with its gene variants studied in cellular and animal models.

Purpose of the Study:

• To investigate the association between single-nucleotide variants (SNVs) in key inflammasome NLRP3 pathway genes (NLRP3, CARD8, CASP1, IL-18, IL-1β) and susceptibility to primary osteoporosis in postmenopausal women.

Main Methods:

• Genotyping of 196 postmenopausal osteoporosis patients and 103 healthy controls using SNV-specific Taqman® probes.
• Association analysis of SNVs in NLRP3, CARD8, CASP1, IL-18, and IL-1β genes.

Main Results:

• An association was found between the NLRP3 rs35829419 CA genotype and lower lumbar spine bone mineral density (BMD) (p=0.001).
• The IL-1β rs16944 AA genotype was linked to higher total hip BMD (p=0.009), while the GG genotype correlated with lower alkaline phosphatase (ALP) levels (p=0.009).
• The IL-18 rs1946519 AA genotype was associated with lower vitamin D levels (p=0.018); OP patients also showed vitamin D and parathyroid hormone deficiencies.

Conclusions:

• Single-nucleotide variants (SNVs) within the NLRP3 inflammasome complex are associated with osteoporosis severity.
• These findings suggest a role for inflammasome pathway genes in bone metabolism and its dysregulation in postmenopausal osteoporosis.